| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $247.3M | — | +19.9% |
| Cost of Revenue | $48.5M | — | +0.4% |
| Gross Profit | $198.8M | — | +25.8% |
| R&D Expense | $52.9M | — | -1.6% |
| SG&A Expense | $26.0M | — | -4.4% |
| Operating Income | $15.3M | — | +161.9% |
| Interest Expense | $3.0M | — | +0.1% |
| Pre-tax Income | $20.6M | — | +206.2% |
| Income Tax | $1.6M | — | -15.9% |
| Net Income | $19.0M | — | +188.9% |
| EPS (Basic) | $0.33 | — | +186.8% |
| EPS (Diluted) | $0.33 | — | +186.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $334.3M | -1.3% | +38.1% |
| Accounts Receivable | $138.1M | -18.3% | +16.4% |
| Current Assets | $1.11B | -4.7% | +13.7% |
| Total Assets | $1.43B | -4.6% | +10.2% |
| Current Liabilities | $686.1M | -7.5% | +25.3% |
| Total Liabilities | $1.44B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $26.5M | — | +459.8% |
| Capital Expenditures | $728K | — | -4.6% |
| Investing Cash Flow | $21.3M | — | +333.7% |
| Financing Cash Flow | -$50.0M | — | -11.2% |
| Free Cash Flow | $25.7M | — | +417.1% |
| +5.0% |
| Stockholders' Equity | -$12.6M | -132.1% | +83.3% |